BBNX

Beta Bionics (BBNX)

About Beta Bionics (BBNX)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Details

Daily high

$29.78

Daily low

$27.86

Price at open

$29.41

52 Week High

$32.71

52 Week Low

$8.89

Market cap

1.3B

Dividend yield

0.00%

Volume

668,237

Avg. volume

739,093

P/E ratio

-16.58

Beta Bionics News